期刊文献+

人间皮素基因中Wnt/β-catenin通路调控元件分析及在卵巢癌细胞中启动子区鉴定 被引量:3

Bioinformatics analysis of Wnt/β-catenin pathway related regulatory elements in human mesothelin gene and identification of promoter in ovarian cancer cells
下载PDF
导出
摘要 目的分析人间皮素基因启动子区中Wnt/β-catenin信号通路相关转录因子T细胞因子/淋巴细胞增强因子(T cell factor/lymphoid enhancer factor,TCF/LEF)结合位点,鉴定间皮素基因在卵巢癌细胞表达相关核心启动子区。方法采用生物信息学方法分析人间皮素基因启动子区域内可能的TCF/LEF转录因子结合位点。克隆人间皮素基因5'端附近1 764 bp启动子序列,对该片段做5'端的不同截短,克隆至p GL3-basic报告基因载体,分别转染人卵巢癌细胞系SKOV3和3-AO,双荧光酶报告基因系统检测不同启动子片段活性。结果人间皮素基因启动子区含有多个潜在的TCF/LEF结合位点。成功克隆扩增间皮素基因启动子区-1456~+308、-164~+308、+47~+308三个片段,经测序证明无误,构建p GL3载体。转染SKOV-3与3-AO细胞后,双荧光酶报告基因系统检测显示-1456~+308与-164~+308片段在两个细胞系中均有较高启动活性,+47~+308片段活性较前两者显著下降(P均<0. 01)。结论含有TCF/LEF转录因子结合位点的-164~+47序列是卵巢癌中间皮素基因表达的核心启动子区,为进一步观察卵巢癌中间皮素基因的表达调控机制奠定基础。 Purpose To analyze the Wnt/β-catenin signaling pathway related TCF/LEF binding sites in human mesothelin gene and to identify the core promoter region of the gene in the ovarian cancer cells.Methods The possible TCF/LEF transcription factor binding sites in the promoter region of human meosothelin gene were analyzed by bioinformatics method.The 1 764 bp promoter sequence near the 5'end of the human mesothelin gene were cloned.The fragments was truncated differently at the 5'end and cloned into pGL3-basic report gene vector and transfected into human ovarian cancer cell lines SKOV-3 and 3-AO.The activity of diffetent promoter fragmentis was detected by double luciferase reporter gene system.Results There were multiple potential TCF/LEF binding sites in the promoter region of the human mesothelin gene.Three fragments of mesothelin gene promoter region-1456-+308、-164-+308、+47-+308 were cloned and amplified successfully,the pGL3 vector was constructed by sequencing.After transfection of SKOV-3 and 3-AO cells,the double luciferase reporter gene system showed that the-1456-+308 fragments and-164-+308 framents had high promoting activity in both cell lines,and the activity of+47-+308 fragments was significantly lower than that of the former two cell lines(P<0.01).Conclusion The-164-+47 sequence containing TCF/LEF transcription factor binding site is the core promoter region of mesothelin gene in ovarian cancer,which lays a foundation for further study on the regulation mechanism of mesothelin gene expression in ovarian cancer.
作者 侯建峰 吴小华 HOU Jian-feng;WU Xiao-hua(Department of Gynecology,Zhuhai Hospital,Guangdong Provincial Hospital of Traditional Chinese Medicine,Zhuhai 519000,China;Department of Obstetrics and Gynecology,Shijiazhuang Obstetrics and Gynecology Hospital,Shijiazhuang 050000,China)
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第3期259-263,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(30572093)
关键词 卵巢肿瘤 间皮素 WNT/Β-CATENIN信号通路 生物信息学 启动子 ovarian neoplasm mesothelin Wnt/β-catenin signal pathway bioinformatics promoter
  • 相关文献

参考文献6

二级参考文献93

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 3CHANG K, PASTAN I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers[J]. Proc Natl Acad Sci USA,1996,93( 1 ) :136- 140.
  • 4BAST RC JR, BADGe-ELL D, LU Z, et al. New tumor markers: CA125 and beyond [ J ]. Int J Gynecol Cancer,2005,5 ( Suppl 3 ) : 274 -281.
  • 5RUMP A, MORIKAWA Y, TANAKA M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion[J].J Biol Chem ,2004 ,279(10) :9190-9198.
  • 6GUBBELS J A, BELISLE J, ONDA M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors[ J]. Mol Cancer, 2006,5( 1 ) :50-58.
  • 7HASSAN R, KREITMAN R J, PASTAN I, et al. Localization of mesothelin in epithelial ovarian cancer[ J ]. Appl Immunohistochem Mol Morphol,2005, 13 ( 3 ) :243-247.
  • 8HUANG C Y, CHENG W F, LEE C N, et al. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor[ J ]. Anticancer Res ,2006,26 ( 6C ) :4721-4728.
  • 9BADGWELL D, LU Z, COI,E L, et al. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta suhunit and urinary hCG beta core fragment [ J ]. Gynecol Oncol,2007,106 ( 3 ) :490-497.
  • 10Pickel H, Lanhousen M, Stettner H, et al. The spread of ovarian cancer[J]. Baillieres Clin Obstet Gynaecol, 1989, 3:3-12.

共引文献34

同被引文献32

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部